Update on lymphoma

Paediatrics and Child Health

Volumn 18, Issue 3, 2008, Pages 112-117

  Morley Jacob, Catherine ^a   Gallop Evans, Eve ^a  

^a Cardiff ^*  (United Kingdom)

Author keywords

Hodgkin; lymphoma; non Hodgkin

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; PROCARBAZINE; VINCRISTINE;

ARTICLE; ATAXIA TELANGIECTASIA; B LYMPHOCYTE; BLOOM SYNDROME; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CHILDHOOD CANCER; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HIGH RISK POPULATION; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; LYMPHOMA; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; RISK FACTOR; T LYMPHOCYTE; TUMOR CELL DESTRUCTION; UNITED KINGDOM;

EID: 40749083179     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2007.12.010     Document Type: Article

References (12)

1. Harris N.L., Jaffe E.S., Diebold J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17 (1999) 3835-3849
2. In: Ries L.A.G., Melbert D., Krapcho M., et al. (Eds). SEER Cancer Statistics Review, 1975-2004 (2005-2007), National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/statfacts/ based on November 2006 SEER data submission, posted to the SEER web site
3. Clavel J., Steliarova-Foucha E., Berger C., et al. Hodgkin's disease incidence and survival in European children and adolescents (1978-1997): report from the automated Cancer Information System project. Eur J Cancer 42 (2006) 2037-2049
4. Lones M.A., Sanger W.G., Le Beau M.M., et al. Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08. J Pediatr Hematol Oncol 26 (2004) 169-178
5. Improving outcomes in children and young people with cancer (2005), NICE, Guidance on cancer services. http://guidance.nice.org.uk/csgcyp
6. Schwartz C.L. Special issues in pediatric Hodgkin's disease. Eur J Haematol 75 (2005) 55-62
7. Schellong G., Pötter R., Brämswig J., et al. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicentre trial DAL-HD-90. J Clin Oncol 17 (1999) 3736-3744
8. Hutchings M., Loft A., Hansen M., et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 107 (2006) 52-59
9. Reiter A., Schrappe M., Ludwig W.D., et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 95 (2000) 416-421
10. Dalle J.-H., Mechinaud F., Michon J., et al. Testicular disease in childhood B-Cell non-Hodgkin's Lymphoma: the French Society of Pediatric Oncology Experience. J Clin Oncol 19 (2001) 2397-2403
11. Le Deley MC, Reiter A, Williams D, et al. Prognostic factors in childhood anaplastic large cell lymphoma: results of the European Intergroup Study. (abstract Lugano 1999).
12. Thomson A.B., and Wallace W.H.B. Treatment of paediatric Hodgkin's disease: a balance of risks. Eur J Cancer 38 (2002) 468-477